Nestle Health Science SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Nestle Health Science SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10650
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nestle Health Science SA (Nestle Health), a subsidiary of Nestle SA, is a health science company that manufactures nutritional and medicinal products derived from botanical plants. The company provides nutritional therapies for chronic conditions related to gastrointestinal diseases, aging problems, critical care or surgery, brain health, pediatrics, metabolic diseases, food allergy, obesity and chronic medical conditions. It caters its products to consumers, patients, doctors, nurses and partners. The company markets its products through a network of distributors located across North America, South America, Europe and Asia. Nestle Health is headquartered in Lausanne, canton of Vaud, Switzerland.

Nestle Health Science SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nestle Health Science SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nestle Health Science SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nestle Health Science SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nestle Health Science SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nestle Health Science SA, Medical Devices Deals, 2012 to YTD 2018 9
Nestle Health Science SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nestle Health Science SA, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Enterome Bioscience Raises USD38.5 Million in Series D Financing 12
Enterome Bioscience Raises USD16.4 Million in Series C Financing 14
Partnerships 15
Codexis Enters into Agreement with Nestle Health Science 15
Enterome Bioscience and Nestle Health Science Form Joint Venture 17
Aimmune Therapeutics Enters Into Agreement With Nestle Health Science 18
CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 19
Nestle Health Science Enters Into Joint Venture With Hutchison China MediTech 20
Pamlab Enters Into Joint Venture With Breckenridge To Distribute Medical Food Products 22
Prometheus Labs Enters Into Research Agreement To Develop Diagnostic Arrays 23
Licensing Agreements 24
Nestle Health Science Enters into Licensing Agreement with Seres Therapeutics 24
Nestle Health Science Enters into Licensing Agreement with Lipid Therapeutics for LT-02 26
Equity Offering 27
Aimmune Therapeutics to Raise Additional USD98 Million in Private Placement of Shares 27
Aimmune Therapeutics Raises USD145 Million in Private Placement of Shares 29
Pronutria Biosciences Raises USD42.5 Million in Equity Investment 30
Seres Health Raises USD65 Million in Financing 31
Acquisition 32
Nestle Health Science Completes Acquisition Of Pamlab, Medical Nutrition Company 32
Nestle Health Science Completes Acquisition Of Minority Stake In Accera 33
Nestle Health Science SA – Key Competitors 34
Nestle Health Science SA – Key Employees 35
Nestle Health Science SA – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Affiliate 37
Joint Venture 37
Recent Developments 38
Other Significant Developments 38
Nov 13, 2018: Nestle Health increases stake in Aimmune Therapeutics 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Nestle Health Science SA, Pharmaceuticals & Healthcare, Key Facts 2
Nestle Health Science SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nestle Health Science SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nestle Health Science SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nestle Health Science SA, Deals By Therapy Area, 2012 to YTD 2018 8
Nestle Health Science SA, Medical Devices Deals, 2012 to YTD 2018 9
Nestle Health Science SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Enterome Bioscience Raises USD38.5 Million in Series D Financing 12
Enterome Bioscience Raises USD16.4 Million in Series C Financing 14
Codexis Enters into Agreement with Nestle Health Science 15
Enterome Bioscience and Nestle Health Science Form Joint Venture 17
Aimmune Therapeutics Enters Into Agreement With Nestle Health Science 18
CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 19
Nestle Health Science Enters Into Joint Venture With Hutchison China MediTech 20
Pamlab Enters Into Joint Venture With Breckenridge To Distribute Medical Food Products 22
Prometheus Labs Enters Into Research Agreement To Develop Diagnostic Arrays 23
Nestle Health Science Enters into Licensing Agreement with Seres Therapeutics 24
Nestle Health Science Enters into Licensing Agreement with Lipid Therapeutics for LT-02 26
Aimmune Therapeutics to Raise Additional USD98 Million in Private Placement of Shares 27
Aimmune Therapeutics Raises USD145 Million in Private Placement of Shares 29
Pronutria Biosciences Raises USD42.5 Million in Equity Investment 30
Seres Health Raises USD65 Million in Financing 31
Nestle Health Science Completes Acquisition Of Pamlab, Medical Nutrition Company 32
Nestle Health Science Completes Acquisition Of Minority Stake In Accera 33
Nestle Health Science SA, Key Competitors 34
Nestle Health Science SA, Key Employees 35
Nestle Health Science SA, Subsidiaries 36
Nestle Health Science SA, Affiliate 37
Nestle Health Science SA, Joint Venture 37

List of Figures
Nestle Health Science SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nestle Health Science SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nestle Health Science SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nestle Health Science SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nestle Health Science SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nestle Health Science SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nestle Health Science SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nestle Health Science SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nestle Health Science SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Nestle Health Science SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Icon Energy Ltd (ICN):企業の財務・戦略的SWOT分析
    Summary Icon Energy Ltd (Icon Energy), formerly Icon Oil NL, is an oil and gas exploration and production company that acquires, explores, and develops oil and gas properties. The company's exploration tenements include ATP 855, PRL's 33-49, ATP 594, ATP 626, ATP 794, ATP 549 West, PEP 170, PEP 172, …
  • Hedberg Landscape & Masonry Supplies:企業の戦略的SWOT分析
    Hedberg Landscape & Masonry Supplies - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Zimmer Biomet Holdings Inc (ZBH)-製薬・医療分野:企業M&A・提携分析
    Summary Zimmer Biomet Holdings Inc (Zimmer Biomet) is a medical device company with focus on musculoskeletal healthcare. It carries out the design, development, manufacture, and marketing of reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, cr …
  • Venari Resources LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Venari Resources LLC (Venari Resources) is an offshore oil and gas production and exploration company that discovers, develops, explores, and produces oil and gas from its deep water blocks located in the Gulf of Mexico. The company owns and operates in drilling wells and discovering barrels …
  • SK Biopharmaceuticals Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary SK Biopharmaceuticals Co Ltd (SK Biopharmaceuticals), a subsidiary of SK Holdings Co Ltd is a developer of drug candidates. The company develops and markets innovative drugs for the treatment of central nervous system. It offers plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL …
  • National Company KazMunayGas:石油・ガス:M&Aディール及び事業提携情報
    Summary National Company KazMunayGas (KazMunayGas) is a state-owned, vertically integrated oil and gas company. It carries out the acquisition, exploration, development, production, processing, transportation, refining and export of hydrocarbons. The company also produces petrochemicals, stores and …
  • Infogroup Inc:企業の戦略・SWOT・財務情報
    Infogroup Inc - Strategy, SWOT and Corporate Finance Report Summary Infogroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Fairfax Media Limited:戦略・SWOT・企業財務分析
    Fairfax Media Limited - Strategy, SWOT and Corporate Finance Report Summary Fairfax Media Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Downer EDI Ltd (DOW):企業の財務・戦略的SWOT分析
    Downer EDI Ltd (DOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Unimedic AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Unimedic AB (Unimedic), formerly Ergobe Pharma AB, a subsidiary of MedCap AB, is a pharmaceutical company which develops, manufactures, distributes and markets pharmaceutical products. The company offers non-licensed, extemporaneous, and licensed pharmaceuticals targeting the therapy areas w …
  • Bank of Queensland Ltd (BOQ)
    Bank of Queensland Ltd (BOQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Florida Keys Electric Cooperative Association, Inc.:企業の戦略的SWOT分析
    Florida Keys Electric Cooperative Association, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compe …
  • Aviragen Therapeutics Inc (AVIR)-医療機器分野:企業M&A・提携分析
    Summary Aviragen Therapeutics Inc (Aviragen) is a pharmaceutical company that carries out anti-infective drug discovery, development and its commercialization to treat respiratory diseases. It has four product candidates in clinical development which address viral infections, namely, vapendavir, ora …
  • Maxion Wheels Inc:企業の戦略的SWOT分析
    Maxion Wheels Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Hangzhou Tigermed Consulting Co Ltd (300347):企業の財務・戦略的SWOT分析
    Summary Hangzhou Tigermed Consulting Co Ltd (Tigermed) is a contract research organization (CRO) that provides clinical trial services. It offers regulatory submission and approval, medical translation and GMP (Good Manufacturing Practice) consulting, medical monitoring, project management, medical …
  • Delong Holdings Limited:企業の戦略・SWOT・財務情報
    Delong Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Delong Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Philippine Long Distance Telephone Co (TEL):企業の財務・戦略的SWOT分析
    Philippine Long Distance Telephone Co (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Key Tronic Corp (KTCC):企業の財務・戦略的SWOT分析
    Summary Key Tronic Corp (Key Tronic) is an electronic manufacturing service provider that offers OEM manufacturing solutions. The company offers services such as product assembly, PCBA, PCBA rapid response center, molding, metal, tooling, program management, supply chain management, quality, testing …
  • The Boston Consulting Group:企業の戦略的SWOT分析
    The Boston Consulting Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Spectris Plc (SXS):企業の財務・戦略的SWOT分析
    Spectris Plc (SXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆